Cart
sales@molnova.com
1-Methylnicotinamide chloride
CAS No. 1005-24-9
1-Methylnicotinamide chloride( 1-methylpyridin-1-ium-3-carboxamide hydrochloride | 3-Carbamoyl-1-methylpyridinium Chloride | Nicotinamide Chloromethylate )
Catalog No. M19773 CAS No. 1005-24-9
Niacin metabolite excreted via the urinary system.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 35 | In Stock |
|
| 200MG | 50 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name1-Methylnicotinamide chloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionNiacin metabolite excreted via the urinary system.
-
DescriptionNiacin metabolite excreted via the urinary system.
-
In VitroImmunofluorescence Cell Line:HMECs Concentration:0.1 and 10 μM Incubation Time:12 and 24 hours Result:Showed polymerization of the G-actin, and strong, clearly visible, parallel F-actin fibers at 10 μM.
-
In Vivo——
-
Synonyms1-methylpyridin-1-ium-3-carboxamide hydrochloride | 3-Carbamoyl-1-methylpyridinium Chloride | Nicotinamide Chloromethylate
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1005-24-9
-
Formula Weight172.62
-
Molecular FormulaC7H9ClN2O
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILES[Cl-].C[n+]1cccc(c1)C(N)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Tridecane-1,13-diol
Tridecane-1,13-diol (1,13-Tridecanediol) can be used as a fungicide and cosmetic additive.
-
NMS-P937
NMS-P937 (NMS1286937), an oral, specific Polo-like Kinase 1 (PLK1) inhibitor, is with IC50 of 2 nM. The specificity of NMS-P937 forPLK1 is 5000-fold higher over PLK2/PLK3.
-
α-Terpineol
α-Terpineol has antitumour anti-inflammatory and antimicrobial activities it inhibits the growth of tumour cells through a mechanism that involves inhibition of the NF-kappaB pathway.
